MedPath

Lay User Evaluation of the Panbio™ HCV Self-Test

Not Applicable
Not yet recruiting
Conditions
HEPATITIS C (HCV)
Registration Number
NCT06605573
Lead Sponsor
Abbott Rapid Dx
Brief Summary

This is a prospective, multi-centre study designed to evaluate the usability of the Panbio™ HCV Self Test, when performed by untrained lay users in an observed study setting. The Panbio™ HCV Self Test detects antibodies to Hepatitis C Virus (HCV). The study validation will be conducted in accordance with the World Health Organisation's technical guidance on Hepatitis C rapid diagnostic tests for professional use and/or self-testing (TSS-16).

Detailed Description

Hepatitis C is a liver disease caused by the hepatitis C virus. The virus can cause both acute and chronic disease, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness. Globally, Hepatitis C virus infects around 71 million people per year, resulting in 700,000 deaths. The WHO estimates that only 21% of individuals chronically infected with HCV are diagnosed, and the WHO HCV targets include increasing the diagnoses to 90% by 2030. WHO guidelines, published in 2021, strongly recommend offering self-testing for HCV as an additional approach to HCV testing services.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
1185
Inclusion Criteria
  • Participant is aged 14 or over
  • Participant agrees to all aspects of the study and is able and willing to provide informed consent / assent with parental consent.
Exclusion Criteria
  • Participant has already participated in this study on a previous occasion.
  • Participant is aware of their HCV status
  • Participant is deemed unfit for the study by the Investigator.
  • Participant has a condition deemed unfit by the Investigator to safely perform or receive the test.
  • Participant is a practising health-care professional or laboratory scientist / technician or has prior medical or laboratory training or experience
  • Participant is currently enrolled in a study to evaluate an investigational drug or vaccine.
  • Participant has a visual impairment that cannot be restored using glasses or contact lenses or is unable to read the Instructions for Use.
  • Participant is unwilling or unable to provide informed consent.
  • Participant has participated in the study "Lay user evaluation of the Panbio™ HCV Self Test: A prospective, multi-centre usability study to evaluate lay user labelling comprehension and test result interpretation".

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Lay user / professional user test result concordance5 months

To assess the concordance between the Panbio™ HCV Self Test, as performed by lay users based on self-collected finger-stick samples, and the Panbio™ HCV Self Test performed by a trained health care worker, who also will collect the finger-stick sample required for the test and perform the test.

Lay user / laboratory test result concordance5 months

To establish clinical performance (concordance with the reference test) for the Panbio™ HCV Self Test, as performed by lay users using finger-stick whole blood samples, when compared to reference testing using venous plasma samples.

Secondary Outcome Measures
NameTimeMethod
Usability evaluation - lay user experience5 months

To assess the usability of the Panbio™ HCV Self Test, as performed by lay users, based on a participant questionnaire evaluation by the lay user participant. The participant questionnaire includes questions to assess the lay users\' experience when performing the test. Most questions have a Yes / No answer option, with free text possible. Some questions require a free text answer.

Usability evaluation - Self-test observer records5 months

To assess the usability of the Panbio™ HCV Self Test, as performed by lay users based on a questionnaire evaluation by the study staff observer. In the observer questionnaire, particular attention will be paid to compliance regarding factors considered critical for the test, such as reading the IFU/ QRG and applying the correct test volume. The observer questionnaire is not reporting scores on a scale, but is recording observations regarding how the users complete each step. For each step, a question is asked whether the user conducted a certain procedure, and a Yes / No answer is requested, with Monitor Notes when applicable.

Lay user / professional user results interpretation concordance5 months

To assess the concordance between the self-test results (obtained by the self-tester) when interpreted by the lay user and by the observer.

© Copyright 2025. All Rights Reserved by MedPath